Other
Benzodiazepines
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Benzodiazepines is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
8
clinical trials
Completed6 · 75%
Terminated2 · 25%
Clinical Trials
Trial Activity
8 trials
Opiates and Benzodiazepines on Driving
Completed·—·Phase 4·NCT03447353·18 enrolled
Benzodiazepines in Opiate Replacement Therapy
Completed·—·N/A·NCT04622995·46,899 enrolled
Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care
Terminated·—·Phase 2·NCT03756038·1 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)